Moody’s revises Holy Redeemer Health System’s outlook to negative

Moody’s Investors Service affirmed its “Baa3” rating on Meadowbrook, Pa.-based Holy Redeemer Health System, affecting $46 million of debt.

Advertisement

The affirmation is a result of the health system’s solid investment position and manageable direct debt leverage. Moody’s also acknowledged HRHS’ weakened operating performance, highly competitive service area and deteriorating patient volume.

The outlook was revised to negative from stable, reflecting the health system’s suppressed operating margins.

More articles on healthcare finance:
Hospitals face $1.6B in Medicare payment cuts after judge dismisses lawsuit: 6 things to know 
Hospital CFOs: 3 things demanding your attention in 2018 
Colorado hospitals now required to post prices: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.